All genes except ADIPOQ in Cluster 1 and Cluster 3 were upregulated in the NFIL3-high group and involved in IL-17 signaling pathways and the type II diabetes mellitus pathway. This evidence concerns the gene IL17A and type 2 diabetes mellitus.